Clinical Trials Logo
  1. Home
  2. Infection Wound
  3. NCT04009772
  4. Details
NCT04009772 Clinical Trial

Single Dose Cefepime Versus Cefuroxime Plus Metronidazole as a Prophylactic Antibiotic During Emergency Intrapartum Cesarean Section

Infection Wound Clinical Trial

Official title:
Single Dose Cefepime Versus Cefuroxime Plus Metronidazole as a Prophylactic Antibiotic: A Randomized Controlled Study

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT04009772
Other study ID # Antibiotic CS
Secondary ID
Status Recruiting
Phase Phase 2/Phase 3
First received
Last updated
Start date July 1, 2019
Est. completion date March 1, 2020

Study information
Verified date July 2019
Source Assiut University
Contact Abdalmageed Abdalmageed
Phone +201007972027
Email drosamast@yahoo.com.au
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Compare between cefepime versus routine antibiotics as a prophylactic antibiotic during emergency cesarean section in a tertiary center of obstetric care

Description:

This is a randomized double blinded study which compare between single dose cefepime versus cefuroxime plus metronidazole during emergency intrapartum cesarean section.

Outcomes will include fever, wound infection, and urinary tract infection.

Recruitment information / eligibility
Status Recruiting
Enrollment 500
Est. completion date March 1, 2020
Est. primary completion date February 1, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 20 Years to 40 Years
Eligibility Inclusion Criteria:

- intrapartum caesarean section

Exclusion Criteria:

- evidence of infection

Study Design

Related Conditions & MeSH terms

Intervention

Drug:
• Cefepime
Antibiotic prophylaxis
• Cefuroxime plus Metronidazole
Antibiotic prophylaxis

Locations
Country Name City State
Egypt Assiut University Assiut

Sponsors (2)
Lead Sponsor Collaborator
Assiut University Yasser Esmat Mohammed

Country where clinical trial is conducted

Egypt, 

Outcome
Type Measure Description Time frame Safety issue
Primary Incidence of surgical site wound infection Examining the wound after one week of the surgery to detect any infection one week
See also
  Status Clinical Trial Phase
Withdrawn NCT04502914 - The Study on Bacterial Load Following Open-to-air Management in Burn Patients. N/A
Completed NCT04516148 - A Randomized, Controlled Trial of the Effectiveness of Perioperative Antibiotics for Reduction of Burn Wound Bacterial Concentration Following Grafting Phase 4
Recruiting NCT04192435 - Tranexamic Acid to Reduce Infection After Gastrointestinal Surgery Phase 4
Not yet recruiting NCT03460262 - Negative Pressure Wound Therapy for Prevention of Groin Infection Following Vascular Surgery N/A
Completed NCT01707654 - Repair of Infective Wound Associated With Nerve Defect in the Finger Using A Bipedicled Nerve Flap N/A
Completed NCT04753723 - The Use of a Platform Wound Device for Reducing Infection Phase 4
Recruiting NCT05153694 - Infectious Complications After Cystectomy: A Prospective Observational Study